GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

Ucb UCB.BR · EUR

Health Care · Euronext Brussels · 🇧🇪 Belgium

Compare

298.80

+2.72%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in EUR, from our data supplier.

FY2025

Revenue

€7.74bn

FY2016FY2025

Net income

€1.56bn

FY2016FY2025

Free cash flow

€1.88bn

FY2016FY2025

Shareholders' equity

€10.87bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue€7.74bn€6.15bn€5.25bn€5.52bn€5.78bn€5.35bn€4.91bn€4.63bn€4.47bn€4.15bn
Gross profit€5.51bn€4.40bn€3.54bn€3.65bn€4.17bn€3.81bn€3.49bn€3.43bn€3.27bn€2.94bn
Research and development€1.82bn€1.78bn€1.63bn€1.67bn€1.63bn€1.57bn€1.27bn€1.16bn€1.06bn€1.02bn
Operating income€1.17bn€1.32bn€604.0m€582.0m€1.27bn€977.0m€1.02bn€1.11bn€1.03bn€796.0m
Net income€1.56bn€1.06bn€343.0m€418.0m€1.06bn€732.0m€792.0m€800.0m€753.0m€520.0m
Diluted earnings per share8.205.481.722.185.463.674.204.244.002.76

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets€18.16bn€17.35bn€15.54bn€15.87bn€14.21bn€13.32bn€11.08bn€10.51bn€9.92bn€10.21bn
Cash and short-term investments€2.47bn€1.76bn€969.0m€1.07bn€1.37bn€1.37bn€1.32bn€1.28bn€1.06bn€761.0m
Total liabilities€7.29bn€7.32bn€6.56bn€6.80bn€5.82bn€6.05bn€4.07bn€4.26bn€4.18bn€4.74bn
Debt€2.13bn€3.03bn€3.04bn€2.90bn€2.12bn€2.75bn€1.28bn€1.50bn€1.57bn€1.60bn
Shareholders' equity€10.87bn€10.03bn€8.97bn€9.06bn€8.39bn€7.27bn€7.04bn€6.31bn€5.81bn€5.58bn
Shares outstanding190m194m200m192m194m200m189m188m188m188m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations€2.16bn€1.24bn€761.0m€1.12bn€1.55bn€1.08bn€882.0m€1.09bn€927.0m€427.0m
Capital spending−€281.0m−€322.0m−€316.0m−€371.0m−€493.0m−€349.0m−€294.0m−€94.0m−€100.0m−€108.0m
Free cash flow€1.88bn€920.0m€445.0m€748.0m€1.06bn€732.0m€588.0m€995.0m€827.0m€319.0m
Dividends paid−€264.0m−€259.0m−€252.0m−€247.0m−€240.0m−€235.0m−€228.0m−€222.0m−€217.0m−€231.0m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
Revenue€4.27bn€4.25bn€3.49bn€3.36bn€2.79bn€2.66bn€2.59bn€2.59bn
Gross profit€3.31bn€3.19bn€2.56bn€2.34bn€1.94bn€1.65bn€1.69bn€1.67bn
Operating income€1.37bn€1.29bn€671.0m€501.0m€323.0m€176.0m€479.0m€118.0m
Net income€1.11bn€1.08bn€475.0m€857.0m€208.0m€32.0m€311.0m€19.0m
Diluted earnings per share5.855.702.504.411.070.161.560.10
Cash from operations€369.0m€1.52bn€639.0m€826.0m€377.0m€469.0m€148.0m€677.0m
Capital spending−€238.0m−€163.0m−€118.0m−€118.0m−€116.0m−€158.0m−€158.0m−€197.0m
Free cash flow€131.0m€1.36bn€521.0m€708.0m€261.0m€311.0m−€10.0m€480.0m
Total assets€20.63bn€18.16bn€17.19bn€17.35bn€15.63bn€15.54bn€15.38bn€15.87bn
Cash and short-term investments€766.0m€2.47bn€1.61bn€1.76bn€428.0m€969.0m€457.0m€1.07bn
Debt€217.0m€2.13bn€2.75bn€2.88bn€2.96bn€2.92bn€2.79bn€2.80bn
Shareholders' equity€11.65bn€10.87bn€9.68bn€10.03bn€8.95bn€8.97bn€9.04bn€9.06bn

Financial ratios

Data as of 17 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin71.1%71.5%67.5%66.2%72.1%71.2%
Operating margin15.1%21.5%11.5%10.5%22.0%18.3%
Net margin20.1%17.3%6.5%7.6%18.3%13.7%
Return on equity14.3%10.6%3.8%4.6%12.6%10.1%
Return on assets8.6%6.1%2.2%2.6%7.4%5.5%
Free cash flow yield6.2%3.9%2.6%3.8%5.1%3.5%
Revenue growth25.8%17.1%-4.8%-4.5%8.0%8.8%
Earnings growth46.3%210.5%-17.9%-60.5%44.5%-7.6%
Current ratio1.38x1.36x1.32x1.06x1.31x1.27x
Debt to equity0.20x0.29x0.33x0.31x0.24x0.37x
Equity ratio59.8%57.8%57.8%57.1%59.0%54.6%
Interest coverage9.11x8.33x4.19x8.20x28.24x14.37x
R&D as a share of sales23.5%28.9%31.0%30.3%28.2%29.3%
Buybacks as a share of market value2.3%2.6%-3.9%0.9%2.9%-5.8%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue12.0%7.7%7.2%
Operating income26.1%3.6%7.3%
Net income55.0%16.3%19.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin71.3%69.4%70.1%70.8%
Operating margin17.9%14.9%16.6%18.1%
Net margin18.9%13.7%14.5%14.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings29.135.145.933.818.423.016.916.816.622.1
Price to sales5.96.13.02.63.43.12.72.92.82.8

Dividends and splits

Per share, in the currency the company pays

Paid for 35 years. Last went ex-dividend on 4 May 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year1.451.391.361.331.301.271.241.21
  • 100-for-1 split · 4 Jan 1999

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.